These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 173766)

  • 21. Plasma lipids on chronic uraemic and transplantation patients.
    Viikari J; Forsström J
    Ann Clin Res; 1979 Jun; 11(3):113-7. PubMed ID: 227315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bezafibrate treatment on the altered lipoprotein profiles in hypertriglyceridemic subjects.
    Norioka M; Suzuki M; Ryomoto K; Ikebuchi M; Harano Y
    J Atheroscler Thromb; 2000; 7(4):198-202. PubMed ID: 11521682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hypothyroidism on blood lipid concentrations in horses.
    Frank N; Sojka JE; Latour MA; McClure SR; Polazzi L
    Am J Vet Res; 1999 Jun; 60(6):730-3. PubMed ID: 10376902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hemodialysis with acetate vs bicarbonate on plasma lipid and lipoprotein levels in uremic patients.
    Morin RJ; Srikantaiah MV; Woodley Z; Davidson WD
    J Dial; 1980; 4(1):9-20. PubMed ID: 7410679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes.
    Olsson AG; Ekelund LG; Carlson LA
    Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased lipoprotein-remnant formation in chronic renal failure.
    Nestel PJ; Fidge NH; Tan MH
    N Engl J Med; 1982 Aug; 307(6):329-33. PubMed ID: 7088097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia.
    Shoji T; Hatsuda S; Tsuchikura S; Kimoto E; Kakiya R; Tahara H; Koyama H; Emoto M; Tabata T; Nishizawa Y
    Atherosclerosis; 2009 Dec; 207(2):579-84. PubMed ID: 19540497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients.
    Hörkkö S; Huttunen K; Läärä E; Kervinen K; Kesäniemi YA
    Ann Med; 1994 Aug; 26(4):271-82. PubMed ID: 7946245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma and lipoprotein lipid responses to four hypolipid drugs.
    Hazzard WR; Wahl PW; Gagne C; Applebaum-Bowden D; Warnick GR; Albers JJ
    Lipids; 1984 Feb; 19(2):73-9. PubMed ID: 6708754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired plasma triglyceride clearance as a feature of both uremic and posttransplant triglyceridemia.
    Savdie E; Gibson JC; Crawford GA; Simons LA; Mahony JF
    Kidney Int; 1980 Dec; 18(6):774-82. PubMed ID: 7009959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
    Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lecithin: cholesterol acyltransferase activity in dialyzed and undialyzed chronic uremic patients.
    Bories PC; Subbaiah PV; Bagdade JD
    Nephron; 1982; 32(1):22-7. PubMed ID: 7177273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal fat metabolism in chronic renal failure.
    Romics L; Makó J
    Acta Med Acad Sci Hung; 1978; 35(3-4):233-40. PubMed ID: 227218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum lipoprotein abnormalities in renal allograft recipients.
    Abbott LK; Elliot C; Aitken JM; Somer JB
    Atherosclerosis; 1978 Jun; 30(2):97-107. PubMed ID: 209800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.